ZACITIDINE IS WELL TOLERATED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND ITS ADMINISTRATION IS ASSOCIATED WITH A REDUCED RISK OF ACUTE GRAFT-VERSUS-HOST DISEASE
Craddock C., Jilani N., Siddique S., Vyas P., Goodyear O., Dennis M., Yin J., Russell N., Snowden J., Crawley C.